Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Chubb
Healthtrust
US Army
Baxter
Johnson and Johnson
Daiichi Sankyo
Medtronic
Mallinckrodt
Accenture

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,310,515

« Back to Dashboard

Summary for Patent: 4,310,515
Title: Pharmaceutical compositions of cisplatin
Abstract:A stable, sterile aqueous solution of cisplatin in a sealed container such as an ampul or vial in unit dosage form suitable for intravenous administration to man is provided which has a concentration of cisplatin between about 0.1 and about 1.0 mgm./ml. and a pH in the range of 2.0 to 3.0 or preferably about 2.5. It can also contain sodium chloride and mannitol.
Inventor(s): Granatek; Edmund S. (Syracuse, NY), Ziemba; Gerald M. (Bridgeport, NY), Grab; Frederick L. (Fayetteville, NY)
Assignee: Bristol-Myers Company (New York, NY)
Application Number:06/080,857
Patent Claim Types:
see list of patent claims
Formulation; Dosage form; Composition;

Drugs Protected by US Patent 4,310,515

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,310,515

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 218134 ➤ Sign Up
Austria 362052 ➤ Sign Up
Austria A164879 ➤ Sign Up
Australia 4383379 ➤ Sign Up
Australia 519873 ➤ Sign Up
Belgium 874596 ➤ Sign Up
Canada 1119954 ➤ Sign Up
Switzerland 619141 ➤ Sign Up
Czechoslovakia 226002 ➤ Sign Up
Cyprus 1159 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Citi
Fuji
McKinsey
Daiichi Sankyo
Johnson and Johnson
Accenture
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot